NCT06393439 Virtual Reality in Functional Movement Disorder
| NCT ID | NCT06393439 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Functional Movement Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2024-05-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the effect of virtual reality (VR) motor tasks on functional movement disorders.
Eligibility Criteria
Inclusion Criteria: * diagnosis of functional tremor (FT) or essential tremor (ET) or healthy control persons * In patients with FT and ET: presence of a constant or intermittent tremor during the neurological examination Exclusion Criteria: * unclear tremor syndrome * essential tremor plus (ET plus) * conditions that interfere with EEG diagnostic (skin conditions, skin infections, wounds) * reflex epilepsy * cervical degeneration or chronic pain syndrome of the cervical spine * severe somatic illness * previous cerebral or head surgery * implanted pacemaker or deep brain stimulation * persons who are unable to consent
Contact & Investigator
Petra Schwingenschuh, MD
PRINCIPAL INVESTIGATOR
Medical University of Graz
Frequently Asked Questions
Who can join the NCT06393439 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Functional Movement Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06393439 currently recruiting?
Yes, NCT06393439 is actively recruiting participants. Contact the research team at daniela.eibl@medunigraz.at for enrollment information.
Where is the NCT06393439 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT06393439 clinical trial?
NCT06393439 is sponsored by Medical University of Graz. The principal investigator is Petra Schwingenschuh, MD at Medical University of Graz. The trial plans to enroll 48 participants.